38165-Vilar, Eduardo

Eduardo Vilar, MD, PhD

Assistant Research Professor of Medicine

(317) 278-3218
RO 225
Indianapolis, IN
Pubmed Logo


Dr. Vilar-Gomez was trained in medicine in Havana, Cuba, where he rose to become a lead Hepatology researcher in the country, being Chief of the Department of Hepatology (2009-2013) and Director of Clinical Research (2007-2013) at the Cuban National Institute of Gastroenterology. Due to his passion and commitment to research, He made the difficult decision to relocate internationally to the Unit for the Clinical Management of Digestive Diseases, Virgen del Rocio University Hospital (Seville, Spain, 2014-2017) to work with Professor Romero-Gomez (European leader in the research field of chronic liver disease and its complications) where he developed clinical and research experience and gained a Master of Science in Clinical Hepatology. In 2017, he moved to the Division of Gastroenterology and Hepatology (Indiana University) to work with Professor Naga Chalasani (lead author of the American Gastroenterology Association management guidelines for NAFLD).

Key Publications

Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. Gastroenterology 2015;149:367-78.e5; quiz e14-5. PMID: 25865049

Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, Aller-de la Fuente R, Metwally M, Eslam M, et al. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study. Gastroenterology 2018;155:443-457.e417. PMID: 29733831

Vilar-Gomez E, Vuppalanchi R, Gawrieh S, Ghabril M, Saxena R, Cummings OW, Chalasani N. Vitamin E Improves Transplant-Free Survival and Hepatic Decompensation Among Patients With Nonalcoholic Steatohepatitis and Advanced Fibrosis. Hepatology 2020;71:495-509. PMID: 30506586

Vilar-Gomez E, Vuppalanchi R, Desai AP, Gawrieh S, Ghabril M, Saxena R, Cummings OW, et al. Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis. Aliment Pharmacol Ther 2019;50:317-328. PMID: 31157422

Looking for patient care?

To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.